Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3690509010 | Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690510017 | Thiabendazole 100 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3690512013 | Tiabendazole 100 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing tiabendazole (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Thiabendazole | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Tiabendazole | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing tiabendazole in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Tiabendazole | true | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Tiabendazole | true | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing only tiabendazole in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Anthelmintic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR